JP2006504793A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006504793A5 JP2006504793A5 JP2004571986A JP2004571986A JP2006504793A5 JP 2006504793 A5 JP2006504793 A5 JP 2006504793A5 JP 2004571986 A JP2004571986 A JP 2004571986A JP 2004571986 A JP2004571986 A JP 2004571986A JP 2006504793 A5 JP2006504793 A5 JP 2006504793A5
- Authority
- JP
- Japan
- Prior art keywords
- propyl
- hydroxy
- acetamide
- difluoro
- benzyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- -1 aromatic iodides Chemical class 0.000 description 9
- 125000006288 3,5-difluorobenzyl group Chemical group [H]C1=C(F)C([H])=C(C([H])=C1F)C([H])([H])* 0.000 description 8
- 238000000034 method Methods 0.000 description 5
- 125000006239 protecting group Chemical group 0.000 description 5
- VKQBMFKBNMKUBE-UHFFFAOYSA-N 2-iodo-2H-chromene Chemical compound C1=CC=C2C=CC(I)OC2=C1 VKQBMFKBNMKUBE-UHFFFAOYSA-N 0.000 description 4
- 150000001412 amines Chemical class 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- 125000006242 amine protecting group Chemical group 0.000 description 2
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- KLGNPEBEDZARRW-UHFFFAOYSA-N 2-iodo-3,4-dihydro-2h-chromene Chemical compound C1=CC=C2OC(I)CCC2=C1 KLGNPEBEDZARRW-UHFFFAOYSA-N 0.000 description 1
- AJVGILMUMCKDOA-IZZNHLLZSA-N 4-[[(2r,3s)-3-acetamido-4-(3,5-difluorophenyl)-2-hydroxybutyl]amino]-4-(3-tert-butylphenyl)-n-methylpiperidine-1-carboxamide Chemical compound C1CN(C(=O)NC)CCC1(C=1C=C(C=CC=1)C(C)(C)C)NC[C@@H](O)[C@@H](NC(C)=O)CC1=CC(F)=CC(F)=C1 AJVGILMUMCKDOA-IZZNHLLZSA-N 0.000 description 1
- WKPYEYRMQAMPIL-LOSJGSFVSA-N 4-[[(2r,3s)-3-acetamido-4-(3,5-difluorophenyl)-2-hydroxybutyl]amino]-4-(3-tert-butylphenyl)piperidine-1-carboxamide Chemical class C([C@H](NC(=O)C)[C@H](O)CNC1(CCN(CC1)C(N)=O)C=1C=C(C=CC=1)C(C)(C)C)C1=CC(F)=CC(F)=C1 WKPYEYRMQAMPIL-LOSJGSFVSA-N 0.000 description 1
- OGRNVANZWCVHPG-UHFFFAOYSA-N CC(=O)NC(Cc1cc(F)cc(F)c1)C(O)CNCC1CNCCC1CC(C)(C)C Chemical compound CC(=O)NC(Cc1cc(F)cc(F)c1)C(O)CNCC1CNCCC1CC(C)(C)C OGRNVANZWCVHPG-UHFFFAOYSA-N 0.000 description 1
- HQCBJRGRUUOUDZ-UHFFFAOYSA-N CC(=O)NC(Cc1cc(F)cc(F)c1)C(O)CNCc1cc(CC(C)(C)C)ccc1C1CCN(CC1)S(C)(=O)=O Chemical compound CC(=O)NC(Cc1cc(F)cc(F)c1)C(O)CNCc1cc(CC(C)(C)C)ccc1C1CCN(CC1)S(C)(=O)=O HQCBJRGRUUOUDZ-UHFFFAOYSA-N 0.000 description 1
- MNJRMJVGHDFZIK-UHFFFAOYSA-N CC(=O)NC(Cc1cc(F)cc(F)c1)C(O)CNCc1cc(CC(C)(C)C)ccc1C1CCNC(=O)C1 Chemical compound CC(=O)NC(Cc1cc(F)cc(F)c1)C(O)CNCc1cc(CC(C)(C)C)ccc1C1CCNC(=O)C1 MNJRMJVGHDFZIK-UHFFFAOYSA-N 0.000 description 1
- YHBNQJFQOQDMAX-UHFFFAOYSA-N CC(=O)NC(Cc1cc(F)cc(F)c1)C(O)CNCc1cc(CC(C)(C)C)ccc1NS(C)(=O)=O Chemical compound CC(=O)NC(Cc1cc(F)cc(F)c1)C(O)CNCc1cc(CC(C)(C)C)ccc1NS(C)(=O)=O YHBNQJFQOQDMAX-UHFFFAOYSA-N 0.000 description 1
- HLUVFENNKGWFJS-UHFFFAOYSA-N CC(=O)NC(Cc1cc(F)cc(F)c1)C(O)CNCc1cc(CC(C)(C)C)ccc1S(=O)(=O)Nc1ccccc1 Chemical compound CC(=O)NC(Cc1cc(F)cc(F)c1)C(O)CNCc1cc(CC(C)(C)C)ccc1S(=O)(=O)Nc1ccccc1 HLUVFENNKGWFJS-UHFFFAOYSA-N 0.000 description 1
- BDGHWFBHHVKZDS-ZRRKCSAHSA-N CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CN[C@@]1(CCCNCC1)c1cccc(c1)C(C)(C)C Chemical compound CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CN[C@@]1(CCCNCC1)c1cccc(c1)C(C)(C)C BDGHWFBHHVKZDS-ZRRKCSAHSA-N 0.000 description 1
- BELZHPFFRRXWOG-LOSJGSFVSA-N CC(C)c1cccc(c1)C1(CCCCC1)NC[C@@H](O)[C@H](Cc1cc(F)c(O)c(F)c1)NC(C)=O Chemical compound CC(C)c1cccc(c1)C1(CCCCC1)NC[C@@H](O)[C@H](Cc1cc(F)c(O)c(F)c1)NC(C)=O BELZHPFFRRXWOG-LOSJGSFVSA-N 0.000 description 1
- QPHISGKKVAYVBI-RRPNLBNLSA-N CCN1CCC(CC1)(NC[C@@H](O)[C@H](Cc1cc(F)cc(F)c1)NC(C)=O)c1cccc(c1)C(C)C Chemical compound CCN1CCC(CC1)(NC[C@@H](O)[C@H](Cc1cc(F)cc(F)c1)NC(C)=O)c1cccc(c1)C(C)C QPHISGKKVAYVBI-RRPNLBNLSA-N 0.000 description 1
- ALZHZMWJXYTXFK-UHFFFAOYSA-N CNS(=O)(=O)c1ccc(CC(C)(C)C)cc1CNCC(O)C(Cc1cc(F)cc(F)c1)NC(C)=O Chemical compound CNS(=O)(=O)c1ccc(CC(C)(C)C)cc1CNCC(O)C(Cc1cc(F)cc(F)c1)NC(C)=O ALZHZMWJXYTXFK-UHFFFAOYSA-N 0.000 description 1
- GZLQGWNIIWORQV-BJKOFHAPSA-N N-[(2S,3R)-1-(3,5-difluorophenyl)-3-hydroxy-4-[[4-(3-propan-2-yloxyphenyl)oxan-4-yl]amino]butan-2-yl]-2-fluoroacetamide Chemical compound CC(C)Oc1cccc(c1)C1(CCOCC1)NC[C@@H](O)[C@H](Cc1cc(F)cc(F)c1)NC(=O)CF GZLQGWNIIWORQV-BJKOFHAPSA-N 0.000 description 1
- YZYIGLICEOAWTR-RBUKOAKNSA-N N-[(2S,3R)-1-(3,5-difluorophenyl)-4-[2-[2-(2,2-dimethylpropyl)-1,3-thiazol-5-yl]propan-2-ylamino]-3-hydroxybutan-2-yl]acetamide Chemical compound FC=1C=C(C[C@@H]([C@@H](CNC(C)(C)C2=CN=C(S2)CC(C)(C)C)O)NC(C)=O)C=C(C=1)F YZYIGLICEOAWTR-RBUKOAKNSA-N 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000010511 deprotection reaction Methods 0.000 description 1
- VFRSADQPWYCXDG-LEUCUCNGSA-N ethyl (2s,5s)-5-methylpyrrolidine-2-carboxylate;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.CCOC(=O)[C@@H]1CC[C@H](C)N1 VFRSADQPWYCXDG-LEUCUCNGSA-N 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- USNPOTLKGIASRB-IZZNHLLZSA-N methyl 4-[[(2r,3s)-3-acetamido-4-(3,5-difluorophenyl)-2-hydroxybutyl]amino]-4-(3-tert-butylphenyl)piperidine-1-carboxylate Chemical compound C1CN(C(=O)OC)CCC1(C=1C=C(C=CC=1)C(C)(C)C)NC[C@@H](O)[C@@H](NC(C)=O)CC1=CC(F)=CC(F)=C1 USNPOTLKGIASRB-IZZNHLLZSA-N 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- ZAMBIRFWYNEAHJ-RBUKOAKNSA-N n-[(2s,3r)-1-(3,5-difluorophenyl)-3-hydroxy-4-[2-[2-(2-methylpropyl)-1,3-thiazol-5-yl]propan-2-ylamino]butan-2-yl]acetamide Chemical compound S1C(CC(C)C)=NC=C1C(C)(C)NC[C@@H](O)[C@@H](NC(C)=O)CC1=CC(F)=CC(F)=C1 ZAMBIRFWYNEAHJ-RBUKOAKNSA-N 0.000 description 1
- BPYMYLLVJHEDAE-IZZNHLLZSA-N n-[(2s,3r)-1-(3,5-difluorophenyl)-3-hydroxy-4-[[1-methyl-4-(3-propan-2-ylphenyl)piperidin-4-yl]amino]butan-2-yl]acetamide Chemical compound CC(C)C1=CC=CC(C2(CCN(C)CC2)NC[C@@H](O)[C@H](CC=2C=C(F)C=C(F)C=2)NC(C)=O)=C1 BPYMYLLVJHEDAE-IZZNHLLZSA-N 0.000 description 1
- ZOLMPEMHCWVHKY-LGOXGGHWSA-N n-[(2s,3r)-1-(3,5-difluorophenyl)-3-hydroxy-4-[[1-oxo-4-(3-propan-2-ylphenyl)thian-4-yl]amino]butan-2-yl]acetamide Chemical compound CC(C)C1=CC=CC(C2(CCS(=O)CC2)NC[C@@H](O)[C@H](CC=2C=C(F)C=C(F)C=2)NC(C)=O)=C1 ZOLMPEMHCWVHKY-LGOXGGHWSA-N 0.000 description 1
- RCOHUTULLLICIN-LHJLODMPSA-N n-[(2s,3r)-1-(3,5-difluorophenyl)-3-hydroxy-4-[[3-(3-propan-2-yloxyphenyl)oxan-3-yl]amino]butan-2-yl]acetamide Chemical compound CC(C)OC1=CC=CC(C2(COCCC2)NC[C@@H](O)[C@H](CC=2C=C(F)C=C(F)C=2)NC(C)=O)=C1 RCOHUTULLLICIN-LHJLODMPSA-N 0.000 description 1
- HBXRDCZVDPEBHE-LHJLODMPSA-N n-[(2s,3r)-1-(3,5-difluorophenyl)-3-hydroxy-4-[[3-(3-propan-2-ylphenyl)oxan-3-yl]amino]butan-2-yl]acetamide Chemical compound CC(C)C1=CC=CC(C2(COCCC2)NC[C@@H](O)[C@H](CC=2C=C(F)C=C(F)C=2)NC(C)=O)=C1 HBXRDCZVDPEBHE-LHJLODMPSA-N 0.000 description 1
- UOKUNDFNXUGJJC-LOSJGSFVSA-N n-[(2s,3r)-1-(3,5-difluorophenyl)-3-hydroxy-4-[[4-(3-propan-2-yloxyphenyl)oxan-4-yl]amino]butan-2-yl]acetamide Chemical compound CC(C)OC1=CC=CC(C2(CCOCC2)NC[C@@H](O)[C@H](CC=2C=C(F)C=C(F)C=2)NC(C)=O)=C1 UOKUNDFNXUGJJC-LOSJGSFVSA-N 0.000 description 1
- QEFGGKHLYDBREI-LOSJGSFVSA-N n-[(2s,3r)-1-(3,5-difluorophenyl)-3-hydroxy-4-[[4-(3-propan-2-ylphenyl)-1-(2,2,2-trifluoroacetyl)piperidin-4-yl]amino]butan-2-yl]acetamide Chemical compound CC(C)C1=CC=CC(C2(CCN(CC2)C(=O)C(F)(F)F)NC[C@@H](O)[C@H](CC=2C=C(F)C=C(F)C=2)NC(C)=O)=C1 QEFGGKHLYDBREI-LOSJGSFVSA-N 0.000 description 1
- AMRFQGHEIBTPHM-LOSJGSFVSA-N n-[(2s,3r)-1-(3,5-difluorophenyl)-3-hydroxy-4-[[4-(3-propan-2-ylphenyl)piperidin-4-yl]amino]butan-2-yl]acetamide Chemical compound CC(C)C1=CC=CC(C2(CCNCC2)NC[C@@H](O)[C@H](CC=2C=C(F)C=C(F)C=2)NC(C)=O)=C1 AMRFQGHEIBTPHM-LOSJGSFVSA-N 0.000 description 1
- CXZXEYUJQRWHPB-LOSJGSFVSA-N n-[(2s,3r)-1-(3,5-difluorophenyl)-3-hydroxy-4-[[4-(3-propan-2-ylphenyl)thian-4-yl]amino]butan-2-yl]acetamide Chemical compound CC(C)C1=CC=CC(C2(CCSCC2)NC[C@@H](O)[C@H](CC=2C=C(F)C=C(F)C=2)NC(C)=O)=C1 CXZXEYUJQRWHPB-LOSJGSFVSA-N 0.000 description 1
- RSZSSBCSMRWEFY-XZOQPEGZSA-N n-[(2s,3r)-1-(3,5-difluorophenyl)-4-[2-[3-(2,2-dimethylpropyl)phenyl]propan-2-ylamino]-3-hydroxybutan-2-yl]-2-fluoroacetamide Chemical compound CC(C)(C)CC1=CC=CC(C(C)(C)NC[C@@H](O)[C@H](CC=2C=C(F)C=C(F)C=2)NC(=O)CF)=C1 RSZSSBCSMRWEFY-XZOQPEGZSA-N 0.000 description 1
- JMLHZBBCZLPDFD-LOSJGSFVSA-N n-[(2s,3r)-1-(3,5-difluorophenyl)-4-[[1,1-dioxo-4-(3-propan-2-ylphenyl)thian-4-yl]amino]-3-hydroxybutan-2-yl]acetamide Chemical compound CC(C)C1=CC=CC(C2(CCS(=O)(=O)CC2)NC[C@@H](O)[C@H](CC=2C=C(F)C=C(F)C=2)NC(C)=O)=C1 JMLHZBBCZLPDFD-LOSJGSFVSA-N 0.000 description 1
- WAHIMGHKKYULHH-RRPNLBNLSA-N n-[(2s,3r)-1-(3,5-difluorophenyl)-4-[[1-ethylsulfonyl-4-(3-propan-2-ylphenyl)piperidin-4-yl]amino]-3-hydroxybutan-2-yl]acetamide Chemical compound C1CN(S(=O)(=O)CC)CCC1(C=1C=C(C=CC=1)C(C)C)NC[C@@H](O)[C@@H](NC(C)=O)CC1=CC(F)=CC(F)=C1 WAHIMGHKKYULHH-RRPNLBNLSA-N 0.000 description 1
- NRNBKONHSZAGCO-IZZNHLLZSA-N n-[(2s,3r)-1-(3,5-difluorophenyl)-4-[[1-formyl-4-(3-propan-2-ylphenyl)piperidin-4-yl]amino]-3-hydroxybutan-2-yl]acetamide Chemical compound CC(C)C1=CC=CC(C2(CCN(CC2)C=O)NC[C@@H](O)[C@H](CC=2C=C(F)C=C(F)C=2)NC(C)=O)=C1 NRNBKONHSZAGCO-IZZNHLLZSA-N 0.000 description 1
- WTTXUEPBGFULOK-ATTQYFOMSA-N n-[(2s,3r)-1-(3,5-difluorophenyl)-4-[[6-(2,2-dimethylpropyl)-3,4-dihydro-2h-chromen-4-yl]amino]-3-hydroxybutan-2-yl]-2-fluoroacetamide Chemical compound C([C@@H]([C@H](O)CNC1CCOC2=CC=C(C=C21)CC(C)(C)C)NC(=O)CF)C1=CC(F)=CC(F)=C1 WTTXUEPBGFULOK-ATTQYFOMSA-N 0.000 description 1
- UEJHCNVNHBILHU-YIKNKFAXSA-N n-[(2s,3r)-4-[[(4r)-4-(3-tert-butylphenyl)-1-methylsulfonylazepan-4-yl]amino]-1-(3,5-difluorophenyl)-3-hydroxybutan-2-yl]acetamide Chemical compound C([C@H](NC(=O)C)[C@H](O)CN[C@]1(CCN(CCC1)S(C)(=O)=O)C=1C=C(C=CC=1)C(C)(C)C)C1=CC(F)=CC(F)=C1 UEJHCNVNHBILHU-YIKNKFAXSA-N 0.000 description 1
- UEJHCNVNHBILHU-GKRYNVPLSA-N n-[(2s,3r)-4-[[(4s)-4-(3-tert-butylphenyl)-1-methylsulfonylazepan-4-yl]amino]-1-(3,5-difluorophenyl)-3-hydroxybutan-2-yl]acetamide Chemical compound C([C@H](NC(=O)C)[C@H](O)CN[C@@]1(CCN(CCC1)S(C)(=O)=O)C=1C=C(C=CC=1)C(C)(C)C)C1=CC(F)=CC(F)=C1 UEJHCNVNHBILHU-GKRYNVPLSA-N 0.000 description 1
- BDGHWFBHHVKZDS-REUBFRLUSA-N n-[(2s,3r)-4-[[(4s)-4-(3-tert-butylphenyl)azepan-4-yl]amino]-1-(3,5-difluorophenyl)-3-hydroxybutan-2-yl]acetamide Chemical compound C([C@H](NC(=O)C)[C@H](O)CN[C@@]1(CCNCCC1)C=1C=C(C=CC=1)C(C)(C)C)C1=CC(F)=CC(F)=C1 BDGHWFBHHVKZDS-REUBFRLUSA-N 0.000 description 1
- MZYUFFBIBGWZPG-RRPNLBNLSA-N n-[(2s,3r)-4-[[1-acetyl-4-(3-propan-2-ylphenyl)piperidin-4-yl]amino]-1-(3,5-difluorophenyl)-3-hydroxybutan-2-yl]acetamide Chemical compound CC(C)C1=CC=CC(C2(CCN(CC2)C(C)=O)NC[C@@H](O)[C@H](CC=2C=C(F)C=C(F)C=2)NC(C)=O)=C1 MZYUFFBIBGWZPG-RRPNLBNLSA-N 0.000 description 1
- YFVOANNZUKFDLA-RRPNLBNLSA-N n-[(2s,3r)-4-[[4-(3-tert-butylphenyl)-1-ethylsulfonylpiperidin-4-yl]amino]-1-(3,5-difluorophenyl)-3-hydroxybutan-2-yl]acetamide Chemical compound C1CN(S(=O)(=O)CC)CCC1(C=1C=C(C=CC=1)C(C)(C)C)NC[C@@H](O)[C@@H](NC(C)=O)CC1=CC(F)=CC(F)=C1 YFVOANNZUKFDLA-RRPNLBNLSA-N 0.000 description 1
- VTOCROULHXLCTO-IZZNHLLZSA-N n-[(2s,3r)-4-[[4-(3-tert-butylphenyl)-1-methylsulfonylpiperidin-4-yl]amino]-1-(3,5-difluorophenyl)-3-hydroxybutan-2-yl]acetamide Chemical compound C([C@H](NC(=O)C)[C@H](O)CNC1(CCN(CC1)S(C)(=O)=O)C=1C=C(C=CC=1)C(C)(C)C)C1=CC(F)=CC(F)=C1 VTOCROULHXLCTO-IZZNHLLZSA-N 0.000 description 1
- ZZNPZEDXBOXPKP-UHFFFAOYSA-N n-[1-(3,5-difluorophenyl)-3-hydroxy-4-[(2-hydroxy-2-methyl-6-propan-2-yl-1,3-dihydroinden-1-yl)amino]butan-2-yl]acetamide Chemical compound C12=CC(C(C)C)=CC=C2CC(C)(O)C1NCC(O)C(NC(C)=O)CC1=CC(F)=CC(F)=C1 ZZNPZEDXBOXPKP-UHFFFAOYSA-N 0.000 description 1
- UBVSMOCCQXRAEM-UHFFFAOYSA-N n-[1-(3,5-difluorophenyl)-3-hydroxy-4-[(2-oxo-5-propan-2-yl-1,3-dihydroindol-3-yl)amino]butan-2-yl]acetamide Chemical compound C12=CC(C(C)C)=CC=C2NC(=O)C1NCC(O)C(NC(C)=O)CC1=CC(F)=CC(F)=C1 UBVSMOCCQXRAEM-UHFFFAOYSA-N 0.000 description 1
- UMUKWUJRBWTHPM-UHFFFAOYSA-N n-[1-(3,5-difluorophenyl)-3-hydroxy-4-[(2-oxo-6-propan-2-yl-1,3-dihydroinden-1-yl)amino]butan-2-yl]acetamide Chemical compound C12=CC(C(C)C)=CC=C2CC(=O)C1NCC(O)C(NC(C)=O)CC1=CC(F)=CC(F)=C1 UMUKWUJRBWTHPM-UHFFFAOYSA-N 0.000 description 1
- SIRXEBJNBLTORW-UHFFFAOYSA-N n-[1-(3,5-difluorophenyl)-3-hydroxy-4-[(2-oxo-6-propan-2-yl-3,4-dihydro-1h-quinolin-4-yl)amino]butan-2-yl]acetamide Chemical compound C12=CC(C(C)C)=CC=C2NC(=O)CC1NCC(O)C(NC(C)=O)CC1=CC(F)=CC(F)=C1 SIRXEBJNBLTORW-UHFFFAOYSA-N 0.000 description 1
- FVCGLJGTGULRQK-UHFFFAOYSA-N n-[1-(3,5-difluorophenyl)-3-hydroxy-4-[(3-hydroxy-3-methyl-7-propan-2-yl-2,4-dihydro-1h-naphthalen-1-yl)amino]butan-2-yl]acetamide Chemical compound C12=CC(C(C)C)=CC=C2CC(C)(O)CC1NCC(O)C(NC(C)=O)CC1=CC(F)=CC(F)=C1 FVCGLJGTGULRQK-UHFFFAOYSA-N 0.000 description 1
- INDOQRFKUMFKIU-UHFFFAOYSA-N n-[1-(3,5-difluorophenyl)-3-hydroxy-4-[(3-oxo-7-propan-2-yl-2,4-dihydro-1h-naphthalen-1-yl)amino]butan-2-yl]acetamide Chemical compound C12=CC(C(C)C)=CC=C2CC(=O)CC1NCC(O)C(NC(C)=O)CC1=CC(F)=CC(F)=C1 INDOQRFKUMFKIU-UHFFFAOYSA-N 0.000 description 1
- BQZAWEGAYUNKOO-UHFFFAOYSA-N n-[1-(3,5-difluorophenyl)-3-hydroxy-4-[[1-(3-propan-2-ylphenyl)cyclobutyl]amino]butan-2-yl]acetamide Chemical compound CC(C)C1=CC=CC(C2(CCC2)NCC(O)C(CC=2C=C(F)C=C(F)C=2)NC(C)=O)=C1 BQZAWEGAYUNKOO-UHFFFAOYSA-N 0.000 description 1
- JXXJIXOVFJAARM-UHFFFAOYSA-N n-[1-(3,5-difluorophenyl)-3-hydroxy-4-[[1-(3-propan-2-ylphenyl)cyclopentyl]amino]butan-2-yl]acetamide Chemical compound CC(C)C1=CC=CC(C2(CCCC2)NCC(O)C(CC=2C=C(F)C=C(F)C=2)NC(C)=O)=C1 JXXJIXOVFJAARM-UHFFFAOYSA-N 0.000 description 1
- SFUTUZARGZOSMO-UHFFFAOYSA-N n-[1-(3,5-difluorophenyl)-3-hydroxy-4-[[2,2,4,4-tetramethyl-3-oxo-1-(3-propan-2-ylphenyl)cyclobutyl]amino]butan-2-yl]acetamide Chemical compound CC(C)C1=CC=CC(C2(NCC(O)C(CC=3C=C(F)C=C(F)C=3)NC(C)=O)C(C(=O)C2(C)C)(C)C)=C1 SFUTUZARGZOSMO-UHFFFAOYSA-N 0.000 description 1
- STIZOSVVIKQECX-UHFFFAOYSA-N n-[1-(3,5-difluorophenyl)-3-hydroxy-4-[[2-(4-methylpiperazin-1-yl)-5-(2-methylpropyl)phenyl]methylamino]butan-2-yl]acetamide Chemical compound C=1C(F)=CC(F)=CC=1CC(NC(C)=O)C(O)CNCC1=CC(CC(C)C)=CC=C1N1CCN(C)CC1 STIZOSVVIKQECX-UHFFFAOYSA-N 0.000 description 1
- QYGNWJKMQGQSNW-UHFFFAOYSA-N n-[1-(3,5-difluorophenyl)-3-hydroxy-4-[[2-(methanesulfonamido)-6-propan-2-yl-2,3-dihydro-1h-inden-1-yl]amino]butan-2-yl]acetamide Chemical compound C12=CC(C(C)C)=CC=C2CC(NS(C)(=O)=O)C1NCC(O)C(NC(C)=O)CC1=CC(F)=CC(F)=C1 QYGNWJKMQGQSNW-UHFFFAOYSA-N 0.000 description 1
- KYQIWSAEJHPQLJ-UHFFFAOYSA-N n-[1-(3,5-difluorophenyl)-3-hydroxy-4-[[2-methyl-5-(3-propan-2-ylphenyl)-1,3,3a,4,6,6a-hexahydrocyclopenta[c]pyrrol-5-yl]amino]butan-2-yl]acetamide Chemical compound CC(C)C1=CC=CC(C2(CC3CN(C)CC3C2)NCC(O)C(CC=2C=C(F)C=C(F)C=2)NC(C)=O)=C1 KYQIWSAEJHPQLJ-UHFFFAOYSA-N 0.000 description 1
- IJMJBLQMUMMSOY-UHFFFAOYSA-N n-[1-(3,5-difluorophenyl)-3-hydroxy-4-[[2-methylsulfonyl-5-(3-propan-2-ylphenyl)-1,3,3a,4,6,6a-hexahydrocyclopenta[c]pyrrol-5-yl]amino]butan-2-yl]acetamide Chemical compound CC(C)C1=CC=CC(C2(CC3CN(CC3C2)S(C)(=O)=O)NCC(O)C(CC=2C=C(F)C=C(F)C=2)NC(C)=O)=C1 IJMJBLQMUMMSOY-UHFFFAOYSA-N 0.000 description 1
- KFBFMCLJWUAMHJ-UHFFFAOYSA-N n-[1-(3,5-difluorophenyl)-3-hydroxy-4-[[3-(3-propan-2-ylphenyl)-3-bicyclo[3.1.0]hexanyl]amino]butan-2-yl]acetamide Chemical compound CC(C)C1=CC=CC(C2(CC3CC3C2)NCC(O)C(CC=2C=C(F)C=C(F)C=2)NC(C)=O)=C1 KFBFMCLJWUAMHJ-UHFFFAOYSA-N 0.000 description 1
- OKMBMSPRRZXOOG-UHFFFAOYSA-N n-[1-(3,5-difluorophenyl)-3-hydroxy-4-[[3-(3-propan-2-ylphenyl)-6-azabicyclo[3.1.0]hexan-3-yl]amino]butan-2-yl]acetamide Chemical compound CC(C)C1=CC=CC(C2(CC3NC3C2)NCC(O)C(CC=2C=C(F)C=C(F)C=2)NC(C)=O)=C1 OKMBMSPRRZXOOG-UHFFFAOYSA-N 0.000 description 1
- SYYRWCZTAHHNLX-UHFFFAOYSA-N n-[1-(3,5-difluorophenyl)-3-hydroxy-4-[[3-(methanesulfonamido)-7-propan-2-yl-1,2,3,4-tetrahydronaphthalen-1-yl]amino]butan-2-yl]acetamide Chemical compound C12=CC(C(C)C)=CC=C2CC(NS(C)(=O)=O)CC1NCC(O)C(NC(C)=O)CC1=CC(F)=CC(F)=C1 SYYRWCZTAHHNLX-UHFFFAOYSA-N 0.000 description 1
- AMNIBXBOTXLWNG-UHFFFAOYSA-N n-[1-(3,5-difluorophenyl)-3-hydroxy-4-[[3-hydroxy-2,2,4,4-tetramethyl-1-(3-propan-2-ylphenyl)cyclobutyl]amino]butan-2-yl]acetamide Chemical compound CC(C)C1=CC=CC(C2(NCC(O)C(CC=3C=C(F)C=C(F)C=3)NC(C)=O)C(C(O)C2(C)C)(C)C)=C1 AMNIBXBOTXLWNG-UHFFFAOYSA-N 0.000 description 1
- WWSIXWQSRQGPIB-UHFFFAOYSA-N n-[1-(3,5-difluorophenyl)-3-hydroxy-4-[[4-(methanesulfonamido)-2-(3-propan-2-ylphenyl)cyclohexyl]amino]butan-2-yl]acetamide Chemical compound CC(C)C1=CC=CC(C2C(CCC(C2)NS(C)(=O)=O)NCC(O)C(CC=2C=C(F)C=C(F)C=2)NC(C)=O)=C1 WWSIXWQSRQGPIB-UHFFFAOYSA-N 0.000 description 1
- MCVGTLNVYCTBQD-UHFFFAOYSA-N n-[1-(3,5-difluorophenyl)-3-hydroxy-4-[[4-(methanesulfonamido)-2-(3-propan-2-ylphenyl)cyclopentyl]amino]butan-2-yl]acetamide Chemical compound CC(C)C1=CC=CC(C2C(CC(C2)NS(C)(=O)=O)NCC(O)C(CC=2C=C(F)C=C(F)C=2)NC(C)=O)=C1 MCVGTLNVYCTBQD-UHFFFAOYSA-N 0.000 description 1
- PNEHHRPUXHLWIL-UHFFFAOYSA-N n-[1-(3,5-difluorophenyl)-3-hydroxy-4-[[4-hydroxy-4-methyl-2-(3-propan-2-ylphenyl)cyclohexyl]amino]butan-2-yl]acetamide Chemical compound CC(C)C1=CC=CC(C2C(CCC(C)(O)C2)NCC(O)C(CC=2C=C(F)C=C(F)C=2)NC(C)=O)=C1 PNEHHRPUXHLWIL-UHFFFAOYSA-N 0.000 description 1
- YJQCBGQQDNKFOY-UHFFFAOYSA-N n-[1-(3,5-difluorophenyl)-3-hydroxy-4-[[4-hydroxy-4-methyl-2-(3-propan-2-ylphenyl)cyclopentyl]amino]butan-2-yl]acetamide Chemical compound CC(C)C1=CC=CC(C2C(CC(C)(O)C2)NCC(O)C(CC=2C=C(F)C=C(F)C=2)NC(C)=O)=C1 YJQCBGQQDNKFOY-UHFFFAOYSA-N 0.000 description 1
- FPZNOHWQBMEFGS-UHFFFAOYSA-N n-[1-(3,5-difluorophenyl)-3-hydroxy-4-[[4-oxo-2-(3-propan-2-ylphenyl)cyclohexyl]amino]butan-2-yl]acetamide Chemical compound CC(C)C1=CC=CC(C2C(CCC(=O)C2)NCC(O)C(CC=2C=C(F)C=C(F)C=2)NC(C)=O)=C1 FPZNOHWQBMEFGS-UHFFFAOYSA-N 0.000 description 1
- NTPLNNHUKSTTDM-UHFFFAOYSA-N n-[1-(3,5-difluorophenyl)-3-hydroxy-4-[[4-oxo-2-(3-propan-2-ylphenyl)cyclopentyl]amino]butan-2-yl]acetamide Chemical compound CC(C)C1=CC=CC(C2C(CC(=O)C2)NCC(O)C(CC=2C=C(F)C=C(F)C=2)NC(C)=O)=C1 NTPLNNHUKSTTDM-UHFFFAOYSA-N 0.000 description 1
- FYCZPMRSVDMGFG-UHFFFAOYSA-N n-[1-(3,5-difluorophenyl)-3-hydroxy-4-[[5-(2-methylpropyl)-2-(1-methylsulfonylpiperidin-4-yl)phenyl]methylamino]butan-2-yl]acetamide Chemical compound C=1C(F)=CC(F)=CC=1CC(NC(C)=O)C(O)CNCC1=CC(CC(C)C)=CC=C1C1CCN(S(C)(=O)=O)CC1 FYCZPMRSVDMGFG-UHFFFAOYSA-N 0.000 description 1
- LOALCEARDBJJNJ-UHFFFAOYSA-N n-[1-(3,5-difluorophenyl)-3-hydroxy-4-[[5-(2-methylpropyl)-2-(4-methylsulfonylpiperazin-1-yl)phenyl]methylamino]butan-2-yl]acetamide Chemical compound C=1C(F)=CC(F)=CC=1CC(NC(C)=O)C(O)CNCC1=CC(CC(C)C)=CC=C1N1CCN(S(C)(=O)=O)CC1 LOALCEARDBJJNJ-UHFFFAOYSA-N 0.000 description 1
- VISUXJMHQBCLES-UHFFFAOYSA-N n-[1-(3,5-difluorophenyl)-3-hydroxy-4-[[5-(2-methylpropyl)-2-piperazin-1-ylphenyl]methylamino]butan-2-yl]acetamide Chemical compound C=1C(F)=CC(F)=CC=1CC(NC(C)=O)C(O)CNCC1=CC(CC(C)C)=CC=C1N1CCNCC1 VISUXJMHQBCLES-UHFFFAOYSA-N 0.000 description 1
- XEABYXKSZQOVPN-UHFFFAOYSA-N n-[1-(3,5-difluorophenyl)-3-hydroxy-4-[[5-(2-methylpropyl)-2-piperidin-4-ylphenyl]methylamino]butan-2-yl]acetamide Chemical compound C=1C(F)=CC(F)=CC=1CC(NC(C)=O)C(O)CNCC1=CC(CC(C)C)=CC=C1C1CCNCC1 XEABYXKSZQOVPN-UHFFFAOYSA-N 0.000 description 1
- YQKVJONRNKKMIO-UHFFFAOYSA-N n-[1-(3,5-difluorophenyl)-3-hydroxy-4-[[5-(3-propan-2-ylphenyl)-2,3,3a,4,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-5-yl]amino]butan-2-yl]acetamide Chemical compound CC(C)C1=CC=CC(C2(CC3CNCC3C2)NCC(O)C(CC=2C=C(F)C=C(F)C=2)NC(C)=O)=C1 YQKVJONRNKKMIO-UHFFFAOYSA-N 0.000 description 1
- KBGJXSCIBIJIKW-UHFFFAOYSA-N n-[1-(3,5-difluorophenyl)-3-hydroxy-4-[[5-(methanesulfonamido)-2-(3-propan-2-ylphenyl)cyclohexyl]amino]butan-2-yl]acetamide Chemical compound CC(C)C1=CC=CC(C2C(CC(CC2)NS(C)(=O)=O)NCC(O)C(CC=2C=C(F)C=C(F)C=2)NC(C)=O)=C1 KBGJXSCIBIJIKW-UHFFFAOYSA-N 0.000 description 1
- HKMNMGHUVGDFGK-UHFFFAOYSA-N n-[1-(3,5-difluorophenyl)-3-hydroxy-4-[[5-hydroxy-2-(3-propan-2-ylphenyl)-3,3a,4,5,6,6a-hexahydro-1h-pentalen-2-yl]amino]butan-2-yl]acetamide Chemical compound CC(C)C1=CC=CC(C2(CC3CC(O)CC3C2)NCC(O)C(CC=2C=C(F)C=C(F)C=2)NC(C)=O)=C1 HKMNMGHUVGDFGK-UHFFFAOYSA-N 0.000 description 1
- ZYBXLYIJHIXSBZ-UHFFFAOYSA-N n-[1-(3,5-difluorophenyl)-3-hydroxy-4-[[5-hydroxy-3a,6a-dimethyl-2-(3-propan-2-ylphenyl)-3,4,5,6-tetrahydro-1h-pentalen-2-yl]amino]butan-2-yl]acetamide Chemical compound CC(C)C1=CC=CC(C2(CC3(C)CC(O)CC3(C)C2)NCC(O)C(CC=2C=C(F)C=C(F)C=2)NC(C)=O)=C1 ZYBXLYIJHIXSBZ-UHFFFAOYSA-N 0.000 description 1
- FRFASWYMLHVCRP-UHFFFAOYSA-N n-[1-(3,5-difluorophenyl)-3-hydroxy-4-[[5-hydroxy-5-methyl-2-(3-propan-2-ylphenyl)cyclohexyl]amino]butan-2-yl]acetamide Chemical compound CC(C)C1=CC=CC(C2C(CC(C)(O)CC2)NCC(O)C(CC=2C=C(F)C=C(F)C=2)NC(C)=O)=C1 FRFASWYMLHVCRP-UHFFFAOYSA-N 0.000 description 1
- DLJHMECJYUXPEV-UHFFFAOYSA-N n-[1-(3,5-difluorophenyl)-3-hydroxy-4-[[5-oxo-2-(3-propan-2-ylphenyl)-1,3,3a,4,6,6a-hexahydropentalen-2-yl]amino]butan-2-yl]acetamide Chemical compound CC(C)C1=CC=CC(C2(CC3CC(=O)CC3C2)NCC(O)C(CC=2C=C(F)C=C(F)C=2)NC(C)=O)=C1 DLJHMECJYUXPEV-UHFFFAOYSA-N 0.000 description 1
- WMZHCEFTKBQBCO-UHFFFAOYSA-N n-[1-(3,5-difluorophenyl)-3-hydroxy-4-[[5-oxo-2-(3-propan-2-ylphenyl)cyclohexyl]amino]butan-2-yl]acetamide Chemical compound CC(C)C1=CC=CC(C2C(CC(=O)CC2)NCC(O)C(CC=2C=C(F)C=C(F)C=2)NC(C)=O)=C1 WMZHCEFTKBQBCO-UHFFFAOYSA-N 0.000 description 1
- KZFDRYFNZRRUMA-UHFFFAOYSA-N n-[1-(3,5-difluorophenyl)-3-hydroxy-4-[[6-(2-methylpropyl)-2,2-dioxo-3,4-dihydro-1h-2$l^{6},1-benzothiazin-4-yl]amino]butan-2-yl]acetamide Chemical compound C12=CC(CC(C)C)=CC=C2NS(=O)(=O)CC1NCC(O)C(NC(C)=O)CC1=CC(F)=CC(F)=C1 KZFDRYFNZRRUMA-UHFFFAOYSA-N 0.000 description 1
- AZVYDHBLFKBPEN-UHFFFAOYSA-N n-[1-(3,5-difluorophenyl)-4-[[4-(2,2-dimethylpropyl)-1-methylsulfonylpiperidin-3-yl]amino]-3-hydroxybutan-2-yl]acetamide Chemical compound C1N(S(C)(=O)=O)CCC(CC(C)(C)C)C1NCC(O)C(NC(=O)C)CC1=CC(F)=CC(F)=C1 AZVYDHBLFKBPEN-UHFFFAOYSA-N 0.000 description 1
- QUWORKFGXXZWCA-UHFFFAOYSA-N n-[1-(3,5-difluorophenyl)-4-[[4-(2,2-dimethylpropyl)-1-methylsulfonylpiperidin-3-yl]methylamino]-3-hydroxybutan-2-yl]acetamide Chemical compound C1N(S(C)(=O)=O)CCC(CC(C)(C)C)C1CNCC(O)C(NC(=O)C)CC1=CC(F)=CC(F)=C1 QUWORKFGXXZWCA-UHFFFAOYSA-N 0.000 description 1
- ZVYWGVFNZNSDMG-UHFFFAOYSA-N n-[1-(3,5-difluorophenyl)-4-[[4-(2,2-dimethylpropyl)piperidin-3-yl]amino]-3-hydroxybutan-2-yl]acetamide Chemical compound C1NCCC(CC(C)(C)C)C1NCC(O)C(NC(=O)C)CC1=CC(F)=CC(F)=C1 ZVYWGVFNZNSDMG-UHFFFAOYSA-N 0.000 description 1
- DGOKCVVNOCHGBR-UHFFFAOYSA-N n-[1-(3,5-difluorophenyl)-4-[[4-(2,2-dimethylpropyl)pyridin-3-yl]amino]-3-hydroxybutan-2-yl]acetamide Chemical compound C=1N=CC=C(CC(C)(C)C)C=1NCC(O)C(NC(=O)C)CC1=CC(F)=CC(F)=C1 DGOKCVVNOCHGBR-UHFFFAOYSA-N 0.000 description 1
- VRKYQXBOKHWOMB-UHFFFAOYSA-N n-[1-(3,5-difluorophenyl)-4-[[4-(2,2-dimethylpropyl)pyridin-3-yl]methylamino]-3-hydroxybutan-2-yl]acetamide Chemical compound C=1N=CC=C(CC(C)(C)C)C=1CNCC(O)C(NC(=O)C)CC1=CC(F)=CC(F)=C1 VRKYQXBOKHWOMB-UHFFFAOYSA-N 0.000 description 1
- OPRPENFGJILLLT-UHFFFAOYSA-N n-[1-(3,5-difluorophenyl)-4-[[5-(2,2-dimethylpropyl)-2-(1-methyl-2-oxopiperidin-4-yl)phenyl]methylamino]-3-hydroxybutan-2-yl]acetamide Chemical compound C1C(=O)N(C)CCC1C1=CC=C(CC(C)(C)C)C=C1CNCC(O)C(NC(C)=O)CC1=CC(F)=CC(F)=C1 OPRPENFGJILLLT-UHFFFAOYSA-N 0.000 description 1
- WGRLZYXWVBASLF-UHFFFAOYSA-N n-[1-(3,5-difluorophenyl)-4-[[5-(2,2-dimethylpropyl)-2-piperidin-4-ylphenyl]methylamino]-3-hydroxybutan-2-yl]acetamide Chemical compound C=1C(CC(C)(C)C)=CC=C(C2CCNCC2)C=1CNCC(O)C(NC(=O)C)CC1=CC(F)=CC(F)=C1 WGRLZYXWVBASLF-UHFFFAOYSA-N 0.000 description 1
- HMHYSWAGWIKTDS-UHFFFAOYSA-N n-[1-[[3-acetamido-4-(3,5-difluorophenyl)-2-hydroxybutyl]amino]-6-propan-2-yl-2,3-dihydro-1h-inden-2-yl]acetamide Chemical compound C12=CC(C(C)C)=CC=C2CC(NC(C)=O)C1NCC(O)C(NC(C)=O)CC1=CC(F)=CC(F)=C1 HMHYSWAGWIKTDS-UHFFFAOYSA-N 0.000 description 1
- SLTZYFLBGNBXKX-UHFFFAOYSA-N n-[3-[[3-acetamido-4-(3,5-difluorophenyl)-2-hydroxybutyl]amino]-4-(3-propan-2-ylphenyl)cyclohexyl]acetamide Chemical compound CC(C)C1=CC=CC(C2C(CC(CC2)NC(C)=O)NCC(O)C(CC=2C=C(F)C=C(F)C=2)NC(C)=O)=C1 SLTZYFLBGNBXKX-UHFFFAOYSA-N 0.000 description 1
- GKOAJFKIKLZHSB-UHFFFAOYSA-N n-[3-[[3-acetamido-4-(3,5-difluorophenyl)-2-hydroxybutyl]amino]-4-(3-propan-2-ylphenyl)cyclopentyl]acetamide Chemical compound CC(C)C1=CC=CC(C2C(CC(C2)NC(C)=O)NCC(O)C(CC=2C=C(F)C=C(F)C=2)NC(C)=O)=C1 GKOAJFKIKLZHSB-UHFFFAOYSA-N 0.000 description 1
- ZNSOJFOOSSPIRM-UHFFFAOYSA-N n-[4-[(5-tert-butyl-2-imidazol-1-ylphenyl)methylamino]-1-(3,5-difluorophenyl)-3,5-dihydroxypentan-2-yl]acetamide Chemical compound C=1C(C(C)(C)C)=CC=C(N2C=NC=C2)C=1CNC(CO)C(O)C(NC(=O)C)CC1=CC(F)=CC(F)=C1 ZNSOJFOOSSPIRM-UHFFFAOYSA-N 0.000 description 1
- HFJUOOVOFIUFIU-UHFFFAOYSA-N n-[4-[(5-tert-butyl-2-imidazol-1-ylphenyl)methylamino]-1-(3,5-difluorophenyl)-3-hydroxypentan-2-yl]acetamide Chemical compound C=1C(F)=CC(F)=CC=1CC(NC(C)=O)C(O)C(C)NCC1=CC(C(C)(C)C)=CC=C1N1C=CN=C1 HFJUOOVOFIUFIU-UHFFFAOYSA-N 0.000 description 1
- TVOOEAVUFFLBFC-UHFFFAOYSA-N n-[4-[[1-acetyl-4-(2,2-dimethylpropyl)piperidin-3-yl]amino]-1-(3,5-difluorophenyl)-3-hydroxybutan-2-yl]acetamide Chemical compound C1N(C(C)=O)CCC(CC(C)(C)C)C1NCC(O)C(NC(=O)C)CC1=CC(F)=CC(F)=C1 TVOOEAVUFFLBFC-UHFFFAOYSA-N 0.000 description 1
- NQCZCQHXYBBUEF-UHFFFAOYSA-N n-[4-[[1-acetyl-4-(2,2-dimethylpropyl)piperidin-3-yl]methylamino]-1-(3,5-difluorophenyl)-3-hydroxybutan-2-yl]acetamide Chemical compound C1N(C(C)=O)CCC(CC(C)(C)C)C1CNCC(O)C(NC(=O)C)CC1=CC(F)=CC(F)=C1 NQCZCQHXYBBUEF-UHFFFAOYSA-N 0.000 description 1
- UTIFAYOZAXRXPV-UHFFFAOYSA-N n-[4-[[2-(1-acetylpiperidin-4-yl)-5-(2,2-dimethylpropyl)phenyl]methylamino]-1-(3,5-difluorophenyl)-3-hydroxybutan-2-yl]acetamide Chemical compound C=1C(CC(C)(C)C)=CC=C(C2CCN(CC2)C(C)=O)C=1CNCC(O)C(NC(=O)C)CC1=CC(F)=CC(F)=C1 UTIFAYOZAXRXPV-UHFFFAOYSA-N 0.000 description 1
- GGZHKYGJJHMOSH-UHFFFAOYSA-N n-[4-[[2-(1-acetylpiperidin-4-yl)-5-(2-methylpropyl)phenyl]methylamino]-1-(3,5-difluorophenyl)-3-hydroxybutan-2-yl]acetamide Chemical compound C=1C(F)=CC(F)=CC=1CC(NC(C)=O)C(O)CNCC1=CC(CC(C)C)=CC=C1C1CCN(C(C)=O)CC1 GGZHKYGJJHMOSH-UHFFFAOYSA-N 0.000 description 1
- LMVVFWSUXYBAIL-UHFFFAOYSA-N n-[4-[[2-(4-acetylpiperazin-1-yl)-5-(2-methylpropyl)phenyl]methylamino]-1-(3,5-difluorophenyl)-3-hydroxybutan-2-yl]acetamide Chemical compound C=1C(F)=CC(F)=CC=1CC(NC(C)=O)C(O)CNCC1=CC(CC(C)C)=CC=C1N1CCN(C(C)=O)CC1 LMVVFWSUXYBAIL-UHFFFAOYSA-N 0.000 description 1
- SMYFTHIPHZZLLN-UHFFFAOYSA-N n-[4-[[2-(benzenesulfonamido)-5-(2,2-dimethylpropyl)phenyl]methylamino]-1-(3,5-difluorophenyl)-3-hydroxybutan-2-yl]acetamide Chemical compound C=1C(CC(C)(C)C)=CC=C(NS(=O)(=O)C=2C=CC=CC=2)C=1CNCC(O)C(NC(=O)C)CC1=CC(F)=CC(F)=C1 SMYFTHIPHZZLLN-UHFFFAOYSA-N 0.000 description 1
- CMHAZPPILXQAQO-UHFFFAOYSA-N n-[4-[[2-acetyl-5-(3-propan-2-ylphenyl)-1,3,3a,4,6,6a-hexahydrocyclopenta[c]pyrrol-5-yl]amino]-1-(3,5-difluorophenyl)-3-hydroxybutan-2-yl]acetamide Chemical compound CC(C)C1=CC=CC(C2(CC3CN(CC3C2)C(C)=O)NCC(O)C(CC=2C=C(F)C=C(F)C=2)NC(C)=O)=C1 CMHAZPPILXQAQO-UHFFFAOYSA-N 0.000 description 1
- JNTIZYXXWKZDHZ-UHFFFAOYSA-N n-[4-[[3-acetamido-4-(3,5-difluorophenyl)-2-hydroxybutyl]amino]-3-(3-propan-2-ylphenyl)cyclohexyl]acetamide Chemical compound CC(C)C1=CC=CC(C2C(CCC(C2)NC(C)=O)NCC(O)C(CC=2C=C(F)C=C(F)C=2)NC(C)=O)=C1 JNTIZYXXWKZDHZ-UHFFFAOYSA-N 0.000 description 1
- FVJNGSKQSVMTDX-UHFFFAOYSA-N n-[4-[[3-acetamido-4-(3,5-difluorophenyl)-2-hydroxybutyl]amino]-6-propan-2-yl-1,2,3,4-tetrahydronaphthalen-2-yl]acetamide Chemical compound C12=CC(C(C)C)=CC=C2CC(NC(C)=O)CC1NCC(O)C(NC(C)=O)CC1=CC(F)=CC(F)=C1 FVJNGSKQSVMTDX-UHFFFAOYSA-N 0.000 description 1
- KTYFGOSMEGKUKH-UHFFFAOYSA-N n-[4-[[3a,6a-dimethyl-5-oxo-2-(3-propan-2-ylphenyl)-1,3,4,6-tetrahydropentalen-2-yl]amino]-1-(3,5-difluorophenyl)-3-hydroxybutan-2-yl]acetamide Chemical compound CC(C)C1=CC=CC(C2(CC3(C)CC(=O)CC3(C)C2)NCC(O)C(CC=2C=C(F)C=C(F)C=2)NC(C)=O)=C1 KTYFGOSMEGKUKH-UHFFFAOYSA-N 0.000 description 1
- GWAPFOYYGXMBMH-UHFFFAOYSA-N n-[4-[[4-(3-tert-butylphenyl)oxan-4-yl]amino]-1-(3,5-difluorophenyl)-3,5-dihydroxypentan-2-yl]acetamide Chemical compound C1COCCC1(C=1C=C(C=CC=1)C(C)(C)C)NC(CO)C(O)C(NC(=O)C)CC1=CC(F)=CC(F)=C1 GWAPFOYYGXMBMH-UHFFFAOYSA-N 0.000 description 1
- HDMDKNWBBJEOCB-UHFFFAOYSA-N n-[4-[[4-(3-tert-butylphenyl)oxan-4-yl]amino]-1-(3,5-difluorophenyl)-3-hydroxybutan-2-yl]acetamide Chemical compound C1COCCC1(C=1C=C(C=CC=1)C(C)(C)C)NCC(O)C(NC(=O)C)CC1=CC(F)=CC(F)=C1 HDMDKNWBBJEOCB-UHFFFAOYSA-N 0.000 description 1
- UXTXWUSOMKQZFS-UHFFFAOYSA-N n-[4-[[4-(3-tert-butylphenyl)oxan-4-yl]amino]-1-(3,5-difluorophenyl)-3-hydroxypentan-2-yl]acetamide Chemical compound C=1C(F)=CC(F)=CC=1CC(NC(C)=O)C(O)C(C)NC1(C=2C=C(C=CC=2)C(C)(C)C)CCOCC1 UXTXWUSOMKQZFS-UHFFFAOYSA-N 0.000 description 1
- LVRREEDPVDGRTD-UHFFFAOYSA-N n-[4-[[6-(2,2-dimethylpropyl)-3,4-dihydro-2h-chromen-4-yl]amino]-1-(3-fluoro-4-hydroxyphenyl)-3-hydroxybutan-2-yl]acetamide Chemical compound C1COC2=CC=C(CC(C)(C)C)C=C2C1NCC(O)C(NC(=O)C)CC1=CC=C(O)C(F)=C1 LVRREEDPVDGRTD-UHFFFAOYSA-N 0.000 description 1
- IJYFXCLFIWWIDE-UHFFFAOYSA-N n-[4-[[6-(2,2-dimethylpropyl)-3,4-dihydro-2h-chromen-4-yl]amino]-3-hydroxy-1-(5-hydroxypyridin-2-yl)butan-2-yl]acetamide Chemical compound C1COC2=CC=C(CC(C)(C)C)C=C2C1NCC(O)C(NC(=O)C)CC1=CC=C(O)C=N1 IJYFXCLFIWWIDE-UHFFFAOYSA-N 0.000 description 1
- ASEBRBPOHPQWKD-UHFFFAOYSA-N n-[4-[[6-acetyl-3-(3-propan-2-ylphenyl)-6-azabicyclo[3.1.0]hexan-3-yl]amino]-1-(3,5-difluorophenyl)-3-hydroxybutan-2-yl]acetamide Chemical compound CC(C)C1=CC=CC(C2(CC3C(N3C(C)=O)C2)NCC(O)C(CC=2C=C(F)C=C(F)C=2)NC(C)=O)=C1 ASEBRBPOHPQWKD-UHFFFAOYSA-N 0.000 description 1
- KSUBPNQRUAPZAN-UHFFFAOYSA-N n-[4-[[7-(2,2-dimethylpropyl)-1,2,3,4-tetrahydronaphthalen-1-yl]amino]-1-(3-fluoro-4-hydroxyphenyl)-3-hydroxybutan-2-yl]acetamide Chemical compound C1CCC2=CC=C(CC(C)(C)C)C=C2C1NCC(O)C(NC(=O)C)CC1=CC=C(O)C(F)=C1 KSUBPNQRUAPZAN-UHFFFAOYSA-N 0.000 description 1
- JLZHHXVXYUTXQY-UHFFFAOYSA-N n-[4-[[7-(2,2-dimethylpropyl)-1,2,3,4-tetrahydronaphthalen-1-yl]amino]-3-hydroxy-1-(5-hydroxypyridin-2-yl)butan-2-yl]acetamide Chemical compound C1CCC2=CC=C(CC(C)(C)C)C=C2C1NCC(O)C(NC(=O)C)CC1=CC=C(O)C=N1 JLZHHXVXYUTXQY-UHFFFAOYSA-N 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229910052723 transition metal Inorganic materials 0.000 description 1
- 150000003624 transition metals Chemical class 0.000 description 1
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40945302P | 2002-09-10 | 2002-09-10 | |
| US45223103P | 2003-03-05 | 2003-03-05 | |
| US49175703P | 2003-08-01 | 2003-08-01 | |
| PCT/US2003/028503 WO2004024081A2 (en) | 2002-09-10 | 2003-09-10 | Acetyl 2-hydroxy-1,3 diaminoalkanes |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010273586A Division JP2011084568A (ja) | 2002-09-10 | 2010-12-08 | アセチル２−ヒドロオキシ−１，３−ダイアミノアルカン |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006504793A JP2006504793A (ja) | 2006-02-09 |
| JP2006504793A5 true JP2006504793A5 (https=) | 2011-02-10 |
Family
ID=31999211
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004571986A Pending JP2006504793A (ja) | 2002-09-10 | 2003-09-10 | アセチル２−ヒドロオキシ−１，３−ダイアミノアルカン |
| JP2010273586A Pending JP2011084568A (ja) | 2002-09-10 | 2010-12-08 | アセチル２−ヒドロオキシ−１，３−ダイアミノアルカン |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010273586A Pending JP2011084568A (ja) | 2002-09-10 | 2010-12-08 | アセチル２−ヒドロオキシ−１，３−ダイアミノアルカン |
Country Status (23)
| Country | Link |
|---|---|
| US (3) | US7244725B2 (https=) |
| EP (1) | EP1565443A4 (https=) |
| JP (2) | JP2006504793A (https=) |
| KR (1) | KR20060057520A (https=) |
| AR (1) | AR043679A1 (https=) |
| AU (1) | AU2003267132A1 (https=) |
| BR (1) | BR0314188A (https=) |
| CA (1) | CA2498248A1 (https=) |
| EA (1) | EA009196B1 (https=) |
| EC (1) | ECSP055696A (https=) |
| GE (1) | GEP20074166B (https=) |
| IS (1) | IS7732A (https=) |
| MA (1) | MA27472A1 (https=) |
| MX (1) | MXPA05002695A (https=) |
| NO (1) | NO20051239L (https=) |
| NZ (1) | NZ539095A (https=) |
| OA (1) | OA12919A (https=) |
| PE (1) | PE20041079A1 (https=) |
| PL (1) | PL376511A1 (https=) |
| TW (1) | TWI336320B (https=) |
| UA (1) | UA84407C2 (https=) |
| UY (1) | UY27967A1 (https=) |
| WO (1) | WO2004024081A2 (https=) |
Families Citing this family (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2507484A1 (en) * | 2002-11-27 | 2004-06-17 | Elan Pharmaceuticals, Inc. | Substituted ureas and carbamates |
| US7521481B2 (en) | 2003-02-27 | 2009-04-21 | Mclaurin Joanne | Methods of preventing, treating and diagnosing disorders of protein aggregation |
| WO2004094413A1 (en) * | 2003-04-21 | 2004-11-04 | Elan Pharmaceuticals, Inc. | Phenacyl 2-hydroxy-3-diaminoalkanes |
| US7763609B2 (en) | 2003-12-15 | 2010-07-27 | Schering Corporation | Heterocyclic aspartyl protease inhibitors |
| WO2005070407A1 (en) * | 2004-01-21 | 2005-08-04 | Elan Pharmaceuticals, Inc. | Methods of treatment of amyloidosis using aspartyl-protease inihibitors |
| WO2005087714A2 (en) * | 2004-03-09 | 2005-09-22 | Elan Pharmaceuticals, Inc. | Methods of treatment of amyloidosis using bi-cyclic aspartyl protease inhibitors |
| JP2007528402A (ja) * | 2004-03-09 | 2007-10-11 | エラン ファーマシューティカルズ，インコーポレイテッド | 置換ヒドロキシエチルアミン系のアスパラギン酸プロテアーゼ阻害薬 |
| JP2007528400A (ja) | 2004-03-09 | 2007-10-11 | エラン ファーマシューティカルズ，インコーポレイテッド | 置換ヒドロキシエチルアミン系のアスパラギン酸プロテアーゼ阻害薬 |
| JP2007528404A (ja) * | 2004-03-09 | 2007-10-11 | エラン ファーマシューティカルズ，インコーポレイテッド | 置換された尿素およびカルバメート、フェナシル−２−ヒドロキシ−３−ジアミノアルカン、ならびにベンズアミド−２−ヒドロキシ−３−ジアミノアルカン系のアスパラギン酸プロテアーゼ阻害薬 |
| US7618978B2 (en) | 2004-04-22 | 2009-11-17 | Eli Lilly And Company | Amides as BACE inhibitors |
| US7585885B2 (en) | 2004-04-22 | 2009-09-08 | Eli Lilly And Company | Pyrrolidine derivatives useful as BACE inhibitors |
| WO2006010095A2 (en) | 2004-07-09 | 2006-01-26 | Elan Pharmaceuticals Inc. | Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors |
| US20060128715A1 (en) * | 2004-07-09 | 2006-06-15 | Jennifer Sealy | Oxime derivative hydroxyethylamine aspartyl-protease inhibitors |
| SV2006002232A (es) | 2004-09-21 | 2006-05-25 | Lilly Co Eli | Inhibidores bace ref. x-16940 |
| EP1853553A1 (en) * | 2005-02-14 | 2007-11-14 | Pfizer Products Incorporated | Substituted hydroxyethylamines |
| US20060223849A1 (en) * | 2005-03-14 | 2006-10-05 | Mjalli Adnan M | Benzazole derivatives, compositions, and methods of use as beta-secretase inhibitors |
| NZ562314A (en) | 2005-04-08 | 2010-02-26 | Comentis Inc | Compounds which inhibit beta-secretase activity and methods of use thereof |
| EP1937638A1 (en) * | 2005-10-12 | 2008-07-02 | Elan Pharmaceuticals Inc. | Methods of treating amyloidosis using aryl-cyclopropyl derivative aspartyl protease inhibitors |
| WO2007047305A1 (en) | 2005-10-12 | 2007-04-26 | Elan Pharmaceuticals, Inc. | Methods of treating amyloidosis using cyclopropyl derivative aspartyl protease inhibitors |
| US7838676B2 (en) | 2005-11-21 | 2010-11-23 | Amgen Inc. | Beta-secretase modulators and methods of use |
| US7872009B2 (en) | 2005-11-21 | 2011-01-18 | Amgen Inc. | Beta-Secretase modulators and methods of use |
| WO2007061670A1 (en) | 2005-11-21 | 2007-05-31 | Amgen Inc. | Beta-secretase modulators and methods of use |
| US7745484B2 (en) | 2005-11-21 | 2010-06-29 | Amgen Inc. | Beta-secretase modulators and methods of use |
| US20090069287A1 (en) * | 2005-11-22 | 2009-03-12 | Pfizer Inc | Substituted azacycloalkanes useful for treating cns conditions |
| JP2010522691A (ja) * | 2006-11-23 | 2010-07-08 | ノバルティス アーゲー | ２−ヒドロキシ−１，３−ジアミノプロパン誘導体 |
| WO2008147544A1 (en) | 2007-05-25 | 2008-12-04 | Amgen Inc. | Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use |
| CL2008001500A1 (es) | 2007-05-25 | 2008-12-26 | Amgen Inc | Compuestos derivados de hidroxietil amina sustituidas, moduladores de betasecretasa; proceso de preparacion de dichos c ompuestos; composicion farmaceutica que los comprende; y su uso para tratar un trastorno neurologico, tal como alzheimer, sindrome de down, demencia degenerativa, entre otros. |
| US7803809B2 (en) | 2008-11-12 | 2010-09-28 | Amgen Inc. | Substituted pyrano [2,3-b] pyridinamine compounds as beta-secretase modulators and methods of use |
| DE102008039083A1 (de) | 2008-08-21 | 2010-02-25 | Bayer Schering Pharma Aktiengesellschaft | Substituierte 5-Aminopyrazole und ihre Verwendung |
| MY148558A (en) * | 2008-09-11 | 2013-04-30 | Amgen Inc | Spiro-tetracyclic ring compounds as betasecretase modulators and methods of use |
| WO2011063233A1 (en) | 2009-11-23 | 2011-05-26 | Amgen Inc. | Amino heteroaryl compounds as beta-secretase modulators and methods of use |
| EP2504330A1 (en) | 2009-11-23 | 2012-10-03 | Amgen Inc. | Amino heteroaryl compounds as beta-secretase modulators and methods of use |
| CA2788363A1 (en) | 2010-01-19 | 2011-07-28 | Amgen Inc. | Amino heteroaryl compounds as beta-secretase modulators and methods of use |
| US8497264B2 (en) | 2010-03-15 | 2013-07-30 | Amgen Inc. | Amino-oxazines and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use |
| EP2547685A1 (en) | 2010-03-15 | 2013-01-23 | Amgen Inc. | Spiro-tetracyclic ring compounds as beta - secretase modulators |
| US9346827B2 (en) | 2011-02-07 | 2016-05-24 | Amgen Inc. | 5-amino-oxazepine and 5-amino-thiazepane compounds as beta secretase antagonists and methods of use |
| WO2013044092A1 (en) | 2011-09-21 | 2013-03-28 | Amgen Inc. | Amino-oxazines and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use |
| WO2014078314A1 (en) | 2012-11-15 | 2014-05-22 | Amgen Inc. | Amino-oxazine and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use |
| MA45795A (fr) | 2016-07-29 | 2019-06-05 | Sunovion Pharmaceuticals Inc | Composés et compositions, et utilisations associées |
| CA3070993C (en) | 2017-08-02 | 2025-05-20 | Sunovion Pharmaceuticals Inc. | ISOCHROMANE COMPOUNDS AND THEIR USES |
| WO2019168874A1 (en) | 2018-02-27 | 2019-09-06 | The Research Foundation For The State University Of New York | Difluoromethoxylation and trifluoromethoxylation compositions and methods for synthesizing same |
| PL243516B1 (pl) | 2020-05-20 | 2023-09-04 | Univ Jagiellonski | Nowe pochodne 9H-fluorenu lub ich farmaceutycznie dopuszczalne sole |
| CN113189089B (zh) * | 2021-03-19 | 2022-05-17 | 四川轻化工大学 | 一种臭氧检测试剂及其制备装置和制备方法 |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61118352A (ja) * | 1984-10-29 | 1986-06-05 | イー・アール・スクイブ・アンド・サンズ・インコーポレイテツド | アミノ酸エステルおよびアミドレニン抑制剤 |
| US5362912A (en) * | 1989-05-23 | 1994-11-08 | Abbott Laboratories | Process for the preparation of a substituted diaminodiol |
| US5539122A (en) * | 1989-05-23 | 1996-07-23 | Abbott Laboratories | Retroviral protease inhibiting compounds |
| ES2217250T3 (es) * | 1990-06-15 | 2004-11-01 | Scios Inc. | Mamifero transgenico, no humano que muestra la patologia de formacion amiloides de la enfermedad de alzheimer. |
| ES2236682T5 (es) * | 1991-01-21 | 2011-03-31 | Elan Pharmaceuticals, Inc. | Ensayo y modelo para la enfermedad de alzheimer. |
| FR2676173B1 (fr) | 1991-05-06 | 1993-08-13 | Oreal | Composition cosmetique contenant un agent alcalinisant sans odeur. |
| AU671093B2 (en) * | 1992-01-07 | 1996-08-15 | Elan Pharmaceuticals, Inc. | Transgenic animal models for alzheimer's disease |
| DE4208756A1 (de) | 1992-03-19 | 1993-09-23 | Basf Ag | Diaminoalkane, verfahren zu deren herstellung sowie kraftstoffe und schmierstoffe, enthaltend die diaminoalkane |
| US5604102A (en) * | 1992-04-15 | 1997-02-18 | Athena Neurosciences, Inc. | Methods of screening for β-amyloid peptide production inhibitors |
| US5766846A (en) * | 1992-07-10 | 1998-06-16 | Athena Neurosciences | Methods of screening for compounds which inhibit soluble β-amyloid peptide production |
| US5968942A (en) * | 1992-08-25 | 1999-10-19 | G. D. Searle & Co. | α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| IS2334B (is) * | 1992-09-08 | 2008-02-15 | Vertex Pharmaceuticals Inc., (A Massachusetts Corporation) | Aspartyl próteasi hemjari af nýjum flokki súlfonamíða |
| CA2170020C (en) * | 1992-12-29 | 2005-08-02 | Dale J. Kempf | Retroviral protease inhibiting compounds |
| AU702293B2 (en) * | 1993-10-27 | 1999-02-18 | Athena Neurosciences, Inc. | Transgenic animals harboring APP allele having Swedish mutation |
| US5877399A (en) * | 1994-01-27 | 1999-03-02 | Johns Hopkins University | Transgenic mice expressing APP-Swedish mutation develop progressive neurologic disease |
| FI974437A7 (fi) * | 1995-06-06 | 1997-12-05 | Pfizer | Substituoituja N-(indoli-2-karbonyyli)amideja ja johdannaisia glykogee nifosforylaasi-inhibiittoreina |
| US6024768A (en) | 1996-07-03 | 2000-02-15 | Hans Schwarzkopf Gmbh & Co. Kg | Diaminoalkane and oxidation colorants |
| EP0958293B1 (en) * | 1997-02-04 | 2005-01-19 | The Regents Of The University Of California | Nanomolar, non-peptide inhibitors of cathepsin d |
| WO1999006369A1 (en) * | 1997-08-01 | 1999-02-11 | University Of Florida | Neuraminidase inhibitors |
| PL205294B1 (pl) | 1998-09-24 | 2010-03-31 | Upjohn Co | Izolowany lub oczyszczony polipeptyd, oczyszczony lub izolowany polinukleotyd, wektor, wektor ekspresyjny, komórka gospodarza, sposób wytwarzania polipeptydu, sposoby identyfikowania czynnika obniżającego, modulującego lub hamującego aktywność, zastosowanie takiego czynnika, izolowany kwas nukleinowy, obejmujący go wektor i ich zastosowanie, sposoby zmniejszania komórkowego wytwarzania beta amyloidu i zastosowanie antysensownego reagenta |
| US6846813B2 (en) * | 2000-06-30 | 2005-01-25 | Pharmacia & Upjohn Company | Compounds to treat alzheimer's disease |
| PE20020276A1 (es) * | 2000-06-30 | 2002-04-06 | Elan Pharm Inc | COMPUESTOS DE AMINA SUSTITUIDA COMO INHIBIDORES DE ß-SECRETASA PARA EL TRATAMIENTO DE ALZHEIMER |
| JP2004502664A (ja) * | 2000-06-30 | 2004-01-29 | イーラン ファーマスーティカルズ、インコーポレイテッド | アルツハイマー病処置用化合物 |
| MXPA03011046A (es) * | 2001-06-01 | 2004-06-25 | Elan Pharm Inc | Hidroxialquilaminas. |
| CN101068772A (zh) * | 2001-07-11 | 2007-11-07 | 艾伦药物公司 | N－(3－氨基－2－羟基－丙基)取代烷基酰胺化合物 |
| AU2002359376B2 (en) * | 2001-11-08 | 2008-01-10 | Elan Pharmaceuticals, Inc. | N, N'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| AU2002360508A1 (en) * | 2001-12-06 | 2003-06-23 | Elan Pharmaceuticals, Inc. | Substituted hydroxyethylamines |
| CA2497979A1 (en) * | 2002-09-06 | 2004-03-18 | Elan Pharmaceuticals, Inc. | 1, 3-diamino-2-hydroxypropane prodrug derivatives |
-
2003
- 2003-09-09 UY UY27967A patent/UY27967A1/es not_active Application Discontinuation
- 2003-09-10 OA OA1200500066A patent/OA12919A/en unknown
- 2003-09-10 MX MXPA05002695A patent/MXPA05002695A/es active IP Right Grant
- 2003-09-10 KR KR1020057004161A patent/KR20060057520A/ko not_active Ceased
- 2003-09-10 PE PE2003000914A patent/PE20041079A1/es not_active Application Discontinuation
- 2003-09-10 BR BR0314188-8A patent/BR0314188A/pt not_active IP Right Cessation
- 2003-09-10 NZ NZ539095A patent/NZ539095A/en not_active IP Right Cessation
- 2003-09-10 EA EA200500472A patent/EA009196B1/ru not_active IP Right Cessation
- 2003-09-10 GE GEAP20038737A patent/GEP20074166B/en unknown
- 2003-09-10 PL PL376511A patent/PL376511A1/pl not_active Application Discontinuation
- 2003-09-10 WO PCT/US2003/028503 patent/WO2004024081A2/en not_active Ceased
- 2003-09-10 UA UAA200502191A patent/UA84407C2/ru unknown
- 2003-09-10 AU AU2003267132A patent/AU2003267132A1/en not_active Abandoned
- 2003-09-10 EP EP03749607A patent/EP1565443A4/en not_active Withdrawn
- 2003-09-10 TW TW092125081A patent/TWI336320B/zh not_active IP Right Cessation
- 2003-09-10 JP JP2004571986A patent/JP2006504793A/ja active Pending
- 2003-09-10 US US10/658,959 patent/US7244725B2/en not_active Expired - Fee Related
- 2003-09-10 AR ARP030103276A patent/AR043679A1/es unknown
- 2003-09-10 CA CA002498248A patent/CA2498248A1/en not_active Abandoned
-
2005
- 2005-03-09 IS IS7732A patent/IS7732A/is unknown
- 2005-03-10 NO NO20051239A patent/NO20051239L/no not_active Application Discontinuation
- 2005-03-21 EC EC2005005696A patent/ECSP055696A/es unknown
- 2005-04-06 MA MA28202A patent/MA27472A1/fr unknown
-
2006
- 2006-06-06 US US11/447,789 patent/US7645780B2/en not_active Expired - Fee Related
-
2009
- 2009-11-23 US US12/624,100 patent/US20100145056A1/en not_active Abandoned
-
2010
- 2010-12-08 JP JP2010273586A patent/JP2011084568A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006504793A5 (https=) | ||
| EP1112251B1 (fr) | Derives d'azetidine, leur preparation et les medicaments les contenant | |
| CN1046274C (zh) | 用作消炎剂的异噁唑啉化合物 | |
| CN1028103C (zh) | 哌啶基苯并咪唑类化合物的制备方法 | |
| US5554633A (en) | Substituted amines as tachykinin receptor antagonists | |
| CN1173948C (zh) | α-取代的芳基磺酰氨基异羟肟酸和制备方法及其组合物 | |
| SK283860B6 (sk) | Sírne deriváty azetidínových zlúčenín, spôsob ich prípravy, farmaceutický prostriedok s ich obsahom a ich použitie | |
| CZ4994A3 (en) | Pyrrolidine derivatives, process of their preparation and medicaments in which said derivatives are comprised | |
| WO2001064633A1 (fr) | Compositions pharmaceutiques contenant des derives de 3-amino-azetidine, les nouveaux derives et leur preparation | |
| CN1882587A (zh) | 三环化合物作为甘氨酸转运抑制剂的用途 | |
| JPH03206086A (ja) | 芳香族アミン化合物、その製造方法、およびそれを含む医薬 | |
| LU84070A1 (fr) | Derives phenylcyclobutyliques,leur procede de preparation et leur application therapeutique | |
| ZA200607542B (en) | MTP inhibiting aryl piperidines or piperazines substituted with 5-membered heterocycles | |
| CA2436526A1 (en) | Heterocyclic sulfonamide inhibitors of beta amyloid production | |
| EP1680402A1 (fr) | Derives de n-[[phenyl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique | |
| TW201712004A (zh) | 吡唑衍生物或其藥理學上容許之鹽 | |
| WO1995015948A1 (fr) | Nouveaux derives de 2-arylalkenyl-azacycloalkanes ligands aux recepteurs sigma, leur procede de preparation et leur application en therapeutique | |
| JP2010506910A5 (https=) | ||
| JPH08291112A (ja) | アリールアルキル−アミンおよびアミド | |
| JP2007508395A5 (https=) | ||
| JP2008520642A5 (https=) | ||
| JP2001515509A (ja) | 新規キノリン−およびナフタレンカルボキサミド、医薬組成物およびカルパインの阻害方法 | |
| JP2005513036A (ja) | キノリン誘導体、それらの製造方法、ならびにｓ−ＣＤ２３により媒介される障害の治療におけるそれらの使用 | |
| CN1052112A (zh) | 萘基唑烷酮衍生物 | |
| CN1128989A (zh) | N-取代的氮杂环羧酸及其酯 |